Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 18;11(12):1654.
doi: 10.3390/brainsci11121654.

Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?

Affiliations
Review

Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?

Lea Krey et al. Brain Sci. .

Abstract

The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since 2020. Links between the newly discovered viral infection and the pathogenesis of neurodegenerative diseases have been investigated in different studies. This review aims to summarize the literature concerning COVID-19 and Parkinson's disease (PD) to give an overview on the interface between viral infection and neurodegeneration with regard to this current topic. We will highlight SARS-CoV-2 neurotropism, neuropathology and the suspected pathophysiological links between the infection and neurodegeneration as well as the psychosocial impact of the pandemic on patients with PD. Some evidence discussed in this review suggests that the SARS-CoV-2 pandemic might be followed by a higher incidence of neurodegenerative diseases in the future. However, the data generated so far are not sufficient to confirm that COVID-19 can trigger or accelerate neurodegenerative diseases.

Keywords: Alzheimer’s disease; COVID-19; Parkinson’s disease; SARS-CoV-2; neurodegeneration; viral infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Arbour N., Côté G., Lachance C., Tardieu M., Cashman N.R., Talbot P.J. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J. Virol. 1999;73:3338–3350. doi: 10.1128/JVI.73.4.3338-3350.1999. - DOI - PMC - PubMed
    1. Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by Human Respiratory Coronaviruses. J. Virol. 2000;74:8913–8921. doi: 10.1128/JVI.74.19.8913-8921.2000. - DOI - PMC - PubMed
    1. Desforges M., le Coupanec A., Brison É., Meessen-Pinard M., Talbot P.J. Neuroinvasive and neurotropic human respiratory coronaviruses: Potential neurovirulent agents in humans. Adv. Exp. Med. Biol. 2014;807:75–96. doi: 10.1007/978-81-322-1777-0_6. - DOI - PMC - PubMed
    1. Jacomy H., Fragoso G., Almazan G., Mushynski W.E., Talbot P.J. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology. 2006;349:335–346. doi: 10.1016/j.virol.2006.01.049. - DOI - PMC - PubMed
    1. Netland J., Meyerholz D.K., Moore S., Cassell M., Perlman S. Severe Acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008;82:7264–7275. doi: 10.1128/JVI.00737-08. - DOI - PMC - PubMed

LinkOut - more resources